|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.3 TWD | -0.18% |
|
+1.11% | -8.70% |
Intech Biopharm Corporation reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 23.65 million compared to TWD 38.9 million a year ago. Net loss was TWD 327.88 million compared to TWD 301.76 million a year ago.
Basic loss per share from continuing operations was TWD 2.82 compared to TWD 2.97 a year ago. Diluted loss per share from continuing operations was TWD 2.82 compared to TWD 2.97 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.70% | 115M | |
| +5.31% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B | |
| +3.90% | 1.65B |
INTECH BIOPHARM CORPORATION 
